The danger of a COVID-19 infection in our patients needs our full attention at this moment. Some of you have been dealing with the infection for a while, and may even have a respite from the onslaught. Others may just be waiting for the wave to arrive….
In addition, there is a need to share our collective experience, ask questions regarding how to deal with different aspects of the pandemic at various stages of the COVID infection. We want to bundle this communication on our twitter account.
We have created a COVID-19 document Library where information can be placed for our members. This information which may be relevant nationally can help others prepare themselves for the onslaught or know what to expect as the wave passes.
Feel free to contact the IUSG Office if you like to submit a document for our members or supply feedback.
Over the next almost 40 years the group has increased in size to over 100 uveitis specialists from all over the world. The IUSG comprises clinicians and researchers who are committed to stimulate, encourage, and intensify a converted effort in research and clinical management of uveitis, with the goal of developing new methods for the diagnosis, treatment, and prevention of the blinding complications of uveitis.
It can affect one or both eyes and the inflammation involves the uveal tract (iris, ciliary body, and choroid), although inflammation of adjacent tissues, such as vitreous humour, retina, and optic nerve also occurs.
Little is known about the causes of uveitis, but in cases of endogenous uveitis in which no link with an infectious agent can be identified, abnormalities of immune regulation have been invoked as the cause.
The IUSG is a charitable organisation under section 501(c)3 of the US Internal Revenue Service code.
The 1023 application and 990 forms for 2013-2017 are available upon request to Prof. Vishali Gupta, Secretary IUSG.